Whole-body hyperthermia combined with chemotherapy and intensity-modulated radiotherapy for treatment of advanced nasopharyngeal carcinoma: a retrospective study with propensity score matching

References

• Tang LL, Chen WQ, Xue WQ, et al. Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett. 2016;374(1):22–30.
   PubMed Web of Science ®Google Scholar
• Wei KR, Zheng RS, Zhang SW, et al. Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin J Cancer. 2017;36(1):90.
   PubMedGoogle Scholar
• Sun X, Su S, Chen C, et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2014;110(3):398–403.
   PubMed Web of Science ®Google Scholar
• Lee AWM, Tung SY, Ng WT, et al. A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity. Cancer. 2017;123(21):4147–4157.
   PubMed Web of Science ®Google Scholar
• Zhang MX, Li J, Shen GP, et al. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up. Eur J Cancer. 2015;51(17):2587–2595.
   PubMed Web of Science ®Google Scholar
• Yi J, Huang X, Gao L, et al. Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma. Radiat Oncol. 2014;9:56.
   PubMed Web of Science ®Google Scholar
• Datta NR, Rogers S, Ordonez SG, et al. Hyperthermia and radiotherapy in the management of head and neck cancers: a systematic review and Meta-analysis. Int J Hyperthermia. 2016;32(1):31–40.
   PubMed Web of Science ®Google Scholar
• Datta NR, Stutz E, Gomez S, et al. Efficacy and safety evaluation of the various therapeutic options in locally advanced cervix cancer: a systematic review and network Meta-Analysis of randomized clinical trials. Int J Radiat Oncol Biol Phys. 2019;103(2):411–437.
   PubMed Web of Science ®Google Scholar
• Datta NR, Puric E, Klingbiel D, et al. Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and Meta-analysis. Int J Radiat Oncol Biol Phys. 2016;94(5):1073–1087.
   PubMed Web of Science ®Google Scholar
• Xu Y, Choi J, Hylander B, et al. Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin. Int J Hyperthermia. 2007;23(6):513–527.
   PubMed Web of Science ®Google Scholar
• Sen A, Capitano ML, Spernyak JA, et al. Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models. Cancer Res. 2011;71(11):3872–3880.
   PubMed Web of Science ®Google Scholar
• Rich LJ, Winslow TB, Alberico RA, et al. Enhanced tumour perfusion following treatment with water-filtered IR-a radiation to the thorax in a patient with head and neck cancer. Int J Hyperthermia. 2016;32(5):539–542.
   PubMed Web of Science ®Google Scholar
• ICRU. Prescribing‑recording‑and‑reporting‑photon‑beam‑therapy‑report‑50. Available from: http://www.icru.org/home/reports/ICRUreport50.pdf.
   Google Scholar
• ICRU. Prescribing‑recording‑and‑reporting‑photon‑beam‑therapy‑report‑62. Available from: http://www.icru.org/home/reports/ICRUreport62.pdf
   Google Scholar
• Blanchard P, Lee A, Marguet S, et al. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC Meta-analysis. Lancet Oncol. 2015;16(6):645–655.
   PubMed Web of Science ®Google Scholar
• Chua MLK, Wee JTS, Hui EP, et al. Nasopharyngeal carcinoma. Lancet. 2016;387(10022):1012–1024.
   PubMed Web of Science ®Google Scholar
• Ren G, Jv H, Tian Z, et al. Ultrasound hyperthermia induces apoptosis in head and neck squamous cell carcinoma: an in vitro study. Med Oral Patol Oral Cir Bucal. 2017;22(3):e289–0.
   PubMed Web of Science ®Google Scholar
• Herman TT, Cathcart KN, et al. Effect of hyperthermia on cis-Diamminedichloroplatinum(II) (rhodamine 123) 2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-Diamminedichloroplatinum(II)-resistant subline. Cancer Res. 1988;48(18):5101–5105.
   PubMed Web of Science ®Google Scholar
• Raoof M, Zhu C, Cisneros BT, et al. Hyperthermia inhibits recombination repair of gemcitabine-stalled replication forks. J Natl Cancer Inst. 2014;106(8):dju183.
   PubMedGoogle Scholar
• Alavizadeh SH, Gheybi F, Nikpoor AR, et al. Therapeutic efficacy of cisplatin thermosensitive liposomes upon mild hyperthermia in C26 tumor bearing BALB/c mice. Mol Pharm. 2017;14(3):712–721.
   PubMed Web of Science ®Google Scholar
• Zhang JF, Yan XM, Lan B, et al. Molecular mechanisms of synergistic induction of apoptosis by the combination therapy with hyperthermia and cisplatin in prostate cancer cells. Biochem Biophys Res Commun. 2016;479(2):159–165.
   PubMed Web of Science ®Google Scholar
• Schaaf L, Schwab M, Ulmer C, et al. Hyperthermia synergizes with chemotherapy by inhibiting PARP1-Dependent DNA replication arrest. Cancer Res. 2016;76(10):2868–2875.
   PubMed Web of Science ®Google Scholar
• Ng GPRSDLDDSCE. A comparison of hyperthermia cisplatin sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment. Cancer Chemother Pharmacol. 1996;37:574–580.
   PubMed Web of Science ®Google Scholar
• Dunne M, Dou YN, Drake DM, et al. Hyperthermia-mediated drug delivery induces biological effects at the tumor and molecular levels that improve cisplatin efficacy in triple negative breast cancer. J Control Release. 2018;282:35–45.
   PubMed Web of Science ®Google Scholar
• Urano M, Kuroda M, Nishimura Y. Invited review for the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia. 1999;15(2):79–107.
   PubMed Web of Science ®Google Scholar
• Bull JMC, Scott GL, Strebel FR, et al. Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: a description of a phase I-II protocol. Int J Hyperthermia. 2008;24(8):649–662.
   PubMed Web of Science ®Google Scholar
• Atmaca A, Al-Batran SE, Neumann A, et al. Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer – a phase II study. Gynecol Oncol. 2009;112(2):384–388.
   PubMed Web of Science ®Google Scholar
• Lassche G, Crezee J, Van Herpen CML. Whole-body hyperthermia in combination with systemic therapy in advanced solid malignancies. Crit Rev Oncol Hematol. 2019;139:67–74.
   PubMed Web of Science ®Google Scholar
• Ogoh S, Sato K, Okazaki K, et al. Blood flow distribution during heat stress: cerebral and systemic blood flow. J Cereb Blood Flow Metab. 2013;33(12):1915–1920.
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Lee CT, Ashcraft KA. The future of biology in driving the field of hyperthermia. Int J Hyperthermia. 2016;32(1):4–13.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Ito Y, Ostapenko VV, et al. Fever-range whole-body heat treatment stimulates antigen-specific T-cell responses in humans. Immunol Lett. 2014;162(1 Pt A):256–261.
   PubMed Web of Science ®Google Scholar
• Repasky EA, Evans SS, Dewhirst MW. Temperature matters! and why it should matter to tumor immunologists. Cancer Immunol Res. 2013;1(4):210–216.
   PubMed Web of Science ®Google Scholar
• Fisher DT, Chen Q, Skitzki JJ, et al. IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells. J Clin Invest. 2011;121(10):3846–3859.
   PubMed Web of Science ®Google Scholar
• Sulyok I, Fleischmann E, Stift A, et al. Effect of preoperative fever-range whole-body hyperthermia on immunological markers in patients undergoing colorectal cancer surgery. Br J Anaesth. 2012;109(5):754–761.
   PubMed Web of Science ®Google Scholar
• Hua Y, Ma S, Fu Z, et al. Intracavity hyperthermia in nasopharyngeal cancer: a phase III clinical study. Int J Hyperthermia. 2011;27(2):180–186.
   PubMed Web of Science ®Google Scholar
• Huilgol NG, Gupta S, Dixit R. Chemoradiation with hyperthermia in the treatment of head and neck cancer. Int J Hyperthermia. 2010;26(1):21–25.
   PubMed Web of Science ®Google Scholar
• Shao X. Comparison the temperature variety of different point inside body during whole body hyperthermia(WBH). St. Louis (MO); 2004; (9th international congress on hyperthermia oncology[C]; 89).
   Google Scholar
• Zhao C, Dai C, Chen X. Whole-body hyperthermia combined with hyperthermic intraperitoneal chemotherapy for the treatment of stage IV advanced gastric cancer. Int J Hyperthermia. 2012;28(8):735–741.
   PubMed Web of Science ®Google Scholar
• Atanackovic D, Pollok K, Faltz C, et al. Patients with solid tumors treated with high-temperature whole body hyperthermia show a redistribution of naive/memory T-cell subtypes. Am J Physiol Regul Integr Comp Physiol. 2006;290(3):R585–94.
   PubMed Web of Science ®Google Scholar
• Zhi -Rong ZHU, Yw C. Hemodynamic changes and oxygen metabolism in patients with malignant tumor during whole-body hyperthermia therapy. Chin J Anesthesiol. 1994;5(1):311–328.
   Google Scholar
• Engelhardt R, Muller U, Weth-Simon R, et al. Treatment of disseminated malignant melanoma with cisplatin in combination with whole-body hyperthermia and doxorubicin. Int J Hyperthermia. 1990;6(3):511–515.
   PubMed Web of Science ®Google Scholar
• Douwes F, Bogovi CJ, Douwes O, et al. Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer. Int J Clin Oncol. 2004;9(2):85–91.
   PubMedGoogle Scholar
• Mohamed F, Marchettini P, Stuart OA, et al. Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia. Ann Surg Oncol. 2003;10(4):463–468.
   PubMed Web of Science ®Google Scholar
• Landon CD, Benjamin SE, Ashcraft KA, et al. A role for the copper transporter Ctr1 in the synergistic interaction between hyperthermia and cisplatin treatment. Int J Hyperthermia. 2013;29(6):528–538.
   PubMed Web of Science ®Google Scholar